However, in order to evaluate the main contributors involved in IL-6 expression during breast cancer bone metastases, numerous in vitro and in vivo studies analyzed tumor cells, bone cells, immune cells, and the organic bone matrix. The gene discussed is IL6; the disease is breast carcinoma.